APC/Firea,,cents 750 anti-human CD3 [OKT3] and 1 more item

The University of Virginia awarded a contract to BioLegend Inc. for laboratory reagents on August 1, 2026, with a total cumulative value of $464. The contract, identified as A207_PO-0464777, involves the delivery of two fluorescent-conjugated monoclonal antibody products to Hao Fan at the contracting organization. The first line item specifies APC/Firefly 750 anti-human CD3 [OKT3] at a unit price of $242.90, while the second line item consists of APC/Firefly 750 anti-human CD19 [SJ25C1] at a unit price of $221.90. Each product is ordered in a quantity of one unit.

These reagents are research-grade immunological products commonly utilized in flow cytometry applications and cellular immunology research. The delivery of these two distinct monoclonal antibody formulations—targeting CD3 and CD19 antigens on human immune cells—indicates the contract supports immunological research activities at the University of Virginia. No specific period of performance or place of performance beyond the University of Virginia has been identified in the contract documentation.